This study presents a potentially valuable exploration of the role of thalamic nuclei in language processing. The results will be of interest to researchers interested in the neurobiology of language.
Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, characteristic patterns of intestinal inflammation. However, there is now substantial ...
This study addresses a key question in developmental cognitive neuroscience by identifying early neural correlates of variability in language learning and showing how syllable tracking and word ...
For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was elegant; the reality proved far more complex. Within a device, molecules ...
Distribution of quantum states generated by a central node to each node, phase encoding at each node, and estimation of arbitrary linear combinations of phases through local measurements. Precise ...
Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.
Department of Radiology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China Background: In dynamic contrast-enhanced T1-weighted imaging (DCE-T1WI) of breast ...
Quantum Computing Inc. (NASDAQ:QUBT) shares declined on Tuesday following the company’s announcement of a significant commercial development in the cybersecurity space. The firm disclosed that a ...
Photon-number-resolving detection of quantum states of light by transition edge sensors. Machine learning methods can be used to improve the sensors' detection rate, while maintaining high efficiency, ...
Gene-specific outcomes in patients with Lynch syndrome treated by immune checkpoint blockade for advanced cancer. Menopausal hormone therapy after a diagnosis of breast cancer in women with a BRCA ...
Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial. This is an ASCO Meeting ...